| PACKAGING TYPE: | 10x15 Alu-alu ( 10 Strip In 1 Box ) |
| COMPOSITION: | Vildagliptin (50mg)+metformin (1000mg) |
| FORMULATION: | Tablet |
| Description: | VIDASAFE-MET 50/1000 Tablet is a combination oral antidiabetic medication containing Vildagliptin 50mg and Metformin 1000mg. It is formulated for type 2 diabetes mellitus to provide enhanced glycemic control through dual mechanisms: Vildagliptin (DPP-4 inhibitor): Increases incretin hormones, improving insulin secretion and reducing glucagon levels. Metformin (Biguanide): Reduces hepatic glucose production, enhances insulin sensitivity, and decreases intestinal glucose absorption. This combination ensures effective blood sugar management, improves patient compliance, and lowers the risk of hypoglycemia compared to some other oral antidiabetic therapies. |
| Side Effects: | Common side effects: Nausea or vomiting Diarrhea or mild stomach upset Headache Dizziness Serious (rare) side effects: Lactic acidosis (rare but serious) Severe allergic reactions Kidney or liver function abnormalities |
| How to Use: | Take as prescribed by your doctor Usually administered once or twice daily, preferably with meals to reduce gastrointestinal discomfort Swallow the tablet whole with water Regular monitoring of blood sugar levels is recommended |
| Precaution: | Use cautiously in patients with kidney or liver impairment Maintain adequate hydration while taking Metformin Inform your doctor about all other medications and medical conditions Not recommended during pregnancy or breastfeeding unless prescribed Monitor blood sugar, kidney function, and liver function regularly |
| Product Benefits: | Provides dual-action blood sugar control in type 2 diabetes Enhances insulin secretion and lowers glucagon levels (Vildagliptin) Reduces liver glucose production and improves insulin sensitivity (Metformin) Suitable for patients not adequately controll |
Frequently Asked Questions
It is used for effective management of type 2 diabetes by combining Vildagliptin and Metformin for dual-action glucose control.
Vildagliptin increases insulin secretion and reduces glucagon, while Metformin lowers hepatic glucose production and improves insulin sensitivity.
Yes, Metformin may support mild weight reduction along with improved glycemic control.












